Home > Healthcare > Outpatient Oncology Infusion Market > Table of Contents

Outpatient Oncology Infusion Market Size - By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), Application (Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer), Therapy (Chemotherapy), Mode & Forecast, 2024 – 2032

  • Report ID: GMI5268
  • Published Date: Sep 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Recent technological advancements in infusion pumps

3.2.1.2    Rising prevalence of cancer across the globe

3.2.1.3    Surging government initiatives for cancer awareness

3.2.2    Industry pitfalls & challenges

3.2.2.1    High costs of cancer therapies

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Technology landscape

3.6    Reimbursement scenario

3.7    Porter's analysis

3.8    PESTEL analysis

3.9    Future market trends

3.10    Gap analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company matrix analysis

4.3    Company market share analysis

4.4    Competitive positioning matrix

4.5    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Infusion pumps

5.3    Intravenous sets

5.4    IV cannulas

5.5    Needleless connectors

Chapter 6   Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Lung cancer

6.3    Liver cancer

6.4    Breast cancer

6.5    Prostate cancer

6.6    Other cancers

Chapter 7   Market Estimates and Forecast, By Therapy, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Chemotherapy

7.3    Targeted therapy

7.4    Immunotherapy

7.5    Hormonal therapy

Chapter 8   Market Estimates and Forecast, By Mode, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    Intramuscular (IM)

8.3    Intravenous (IV)

8.4    Subcutaneous

8.5    Other modes

Chapter 9   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

9.1    Key trends

9.2    North America

9.2.1    U.S.

9.2.2    Canada

9.3    Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.3.6    Netherlands

9.3.7    Rest of Europe

9.4    Asia Pacific

9.4.1    China

9.4.2    Japan

9.4.3    India

9.4.4    Australia

9.4.5    South Korea

9.4.6    Rest of Asia Pacific

9.5    Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Argentina

9.5.4    Rest of Latin America

9.6    Middle East and Africa

9.6.1    South Africa

9.6.2    Saudi Arabia

9.6.3    UAE

9.6.4    Rest of Middle East and Africa

Chapter 10   Company Profiles

10.1    B. Braun Melsungen AG

10.2    Baxter

10.3    Becton, Dickinson, and Company

10.4    Fresenius Kabi

10.5    ICU Medical, Inc

10.6    IRadimed Corporation

10.7    Medtronic PLC

10.8    Micrel Medical Devices SA

10.9    Moog, Inc.

10.10    Nipro Corporation

10.11    Roche Diagnostics

10.12    Smiths Medical

10.13    Teleflex, Inc.

10.14    Terumo Corporation
 

Authors: Mariam Faizullabhoy , Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 150
  • Countries covered: 23
  • Pages: 110
 Download Free Sample